Connection

Karel Kostev to Blood Glucose

Back to Details
This is a "connection" page, showing publications Karel Kostev has written about Blood Glucose.
Karel Kostev
Connection Strength
0.972
Blood Glucose
  1. Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings?. Int J Clin Pharmacol Ther. 2018 Sep; 56(9):411-416.
    View in: PubMed
    Score: 0.268
  2. Association of characteristics of people with type 2 diabetes mellitus with discordant values of fasting glucose and HbA1c. J Diabetes. 2018 Dec; 10(12):934-941.
    View in: PubMed
    Score: 0.267
  3. Changes in patient characteristics, glucose lowering treatment, glycemic control and complications in type 2 diabetes in general practices (Disease Analyzer, Germany: 2008-2016). Postgrad Med. 2018 Mar; 130(2):244-250.
    View in: PubMed
    Score: 0.256
  4. Prescription Patterns and Disease Control in Type 2 Diabetes Mellitus Patients in Nursing Home and Home Care Settings: A Retrospective Analysis in Germany. J Diabetes Sci Technol. 2018 01; 12(1):136-139.
    View in: PubMed
    Score: 0.061
  5. Regional differences in insulin therapy regimens in five European countries?. Int J Clin Pharmacol Ther. 2017 May; 55(5):403-408.
    View in: PubMed
    Score: 0.061
  6. Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study. J Diabetes Sci Technol. 2017 05; 11(3):590-596.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.